The invention relates to the use of cyclic compounds as ligands of integrin receptors, in particular as ligands of the α
V
β
3
integrin receptor, the novel compounds themselves, their use, and pharmaceutical preparations comprising these compounds.
Novel Substituted Diaryl Azepine Derivatives as Integrin Ligands
申请人:Geneste Herve
公开号:US20100048536A1
公开(公告)日:2010-02-25
The invention relates to novel compounds which bind to integrin receptors, their use as ligands of integrin receptors, in particular as ligands of the α
v
β
3
integrin receptor, and pharmaceutical preparations comprising these compounds.